HealthStream Announces $10M Stock Buyback Program

The healthcare technology company plans to repurchase up to 1.7% of its outstanding shares.

Mar. 14, 2026 at 2:13am

HealthStream (NASDAQ:HSTM), a provider of workforce development and learning management solutions for healthcare organizations, has announced that its board of directors has approved a $10 million stock buyback program. The company plans to repurchase up to 1.7% of its outstanding shares through open market purchases, indicating that the board believes the stock is currently undervalued.

Why it matters

Stock buyback programs are often seen as a sign of confidence by a company's leadership in the underlying strength of the business and its future prospects. HealthStream's decision to authorize this buyback suggests the company believes its shares are trading at a discount to their intrinsic value, which could provide an opportunity for the company to enhance shareholder value.

The details

The $10 million stock buyback program will allow HealthStream to repurchase up to 1.7% of its outstanding shares through open market purchases. This type of buyback authorization is a common way for publicly traded companies to return capital to shareholders when the board believes the stock is undervalued.

  • HealthStream's board of directors approved the stock buyback program on Friday, March 13th, 2026.

The players

HealthStream

A Nashville, Tennessee-based provider of workforce development and learning management solutions for healthcare organizations.

Got photos? Submit your photos here. ›

What’s next

The company has not provided a specific timeline for when it will begin executing the stock buyback program.

The takeaway

HealthStream's decision to authorize a $10 million stock buyback program suggests the company's leadership believes its shares are currently undervalued, providing an opportunity to enhance shareholder value through repurchases. This move is a common strategy for publicly traded companies to return capital to investors when the board is confident in the company's long-term prospects.